UNSPSC 51285305: Nifurzide

This classification denotes an anti-infective agent with the molecular formula C12H8N4O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) Z35R6K4C26, chemically known as 2-thiophenecarboxylic acid, 5-nitro-, (3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide but more generally known as nifurzide, which bears US NIH Compound Identifier 9571044. European Medicines Agency schedules Nifurzide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09283MIG.

UNSPSC 51285305 Nifurzide, a Commodity code, does not align with recent state and local procurement activity. The code nominally describes a specific pharmaceutical compound, but the opportunities tagged under it encompass naloxone and drug deactivation systems, therapeutic pharmacy initiatives involving direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers—none of which are nifurzide or pharmaceutical products in the nifurzide family. The mismatch suggests either a systematic tagging error in the source data or that this code is rarely used for active procurement.

The four recent opportunities show activity across Florida county health systems, state HHS agencies, municipal fire departments, and regional cooperative purchasing alliances, but none involve nifurzide procurement. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission issued an RFI (HHS0017013, due April 3, 2026) regarding direct-to-manufacturer pharmacy programs; the City of Tampa issued an IFB (26P00145, due March 13, 2026, estimated contract value $700,000.00) for medical and first aid supplies for its Fire Department Rescue Division; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic pharmaceuticals and OTC products. Given the absence of nifurzide-specific demand signals in recent state and local procurement records, this code shows little current relevance to pharmaceutical supply chain activity at the state and local level.